Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Intervention for Bowel Function in Rectal Cancer Patients with Prophylactic Ileostomy
NCT07369830Recruiting
- Sponsor
- Huashan Hospital
- Start
- Oct 2025
- Primary completion
- Mar 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of clostridium butyricum in rectal cancer (3 arms), sponsored by Huashan Hospital. Primary endpoints: Low Anterior Resection Syndrome Score and Microbial diversity. Started Oct 2025; status: recruiting.
02
Drugs
clostridium butyricum
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07369830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369830.